Meta wants to sell AI compute. Now what?
July 14, 2026 Meta’s Next Business Might Surprise You Cloud capacity for sale, Iris chips in September, and earnings on…
Eli Lilly Is Growing Like a Software Company. The Valuation Debate Is Getting Loud.
Mounjaro sales up 125% in Q1. A new pill just launched. Q2 earnings could reset the story again.
The Pentagon Has a Hard Deadline. There Are Only Two Companies That Can Meet It.
A January 2027 ban on Chinese rare earth magnets just became the most overlooked supply shock in defense history.
BABA jumped 11%. Now what?
July 13, 2026 Alibaba Is Down 42% From Its High One session changed the story. Here is what actually happened.…
MercadoLibre Is Down About 37% From Its High. Its Fastest Growth in Years Just Got Ignored.
Revenue grew 49% last quarter. The market punished it anyway.
The AI Chip Crisis Nobody Is Measuring Correctly
Inside the invisible yield bottleneck deciding which AI factories actually ship.
The Law That Rewired Global Drug Manufacturing
A single piece of legislation just forced every major pharma company to find new factories overnight.
Eli Lilly Is Down From Its High. Its Business Has Never Been Stronger.
Q1 revenue grew 56% and Mounjaro just became the world’s best-selling drug.
MSFT Is Down ~30% From Its High and Reports July 29
Azure grew 40% last quarter. The stock is trading like it didn’t.
JPMorgan Reports Tuesday. The Whole Market Will Be Watching.
Q2 bank earnings kick off July 14 and set the tone for the rest of the season.